Align Technology, Inc. (ALGN)
USD 154.24
(-5.94%)
USD 154.24
(-5.94%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.07 Billion USD | 4.13% |
| 2022 | 1.97 Billion USD | 1.06% |
| 2021 | 1.95 Billion USD | 42.36% |
| 2020 | 1.37 Billion USD | 11.93% |
| 2019 | 1.22 Billion USD | 25.28% |
| 2018 | 981.3 Million USD | 28.55% |
| 2017 | 763.33 Million USD | 34.78% |
| 2016 | 566.37 Million USD | 25.45% |
| 2015 | 451.47 Million USD | 17.31% |
| 2014 | 384.86 Million USD | 14.24% |
| 2013 | 336.88 Million USD | 14.51% |
| 2012 | 294.2 Million USD | 8.59% |
| 2011 | 270.92 Million USD | 32.29% |
| 2010 | 204.8 Million USD | -23.06% |
| 2009 | 266.18 Million USD | 30.88% |
| 2008 | 203.38 Million USD | 15.92% |
| 2007 | 175.44 Million USD | -2.05% |
| 2006 | 179.11 Million USD | 27.13% |
| 2005 | 140.89 Million USD | 33.5% |
| 2004 | 105.53 Million USD | 15.85% |
| 2003 | 91.09 Million USD | -6.7% |
| 2002 | 97.64 Million USD | -0.77% |
| 2001 | 98.39 Million USD | 45.55% |
| 2000 | 67.6 Million USD | 405.95% |
| 1999 | 13.36 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 549.13 Million USD | 12.66% |
| 2024 Q3 | 519.41 Million USD | -5.56% |
| 2024 Q2 | 549.96 Million USD | 0.15% |
| 2023 Q4 | 487.43 Million USD | -1.87% |
| 2023 Q1 | 527.13 Million USD | 6.8% |
| 2023 Q2 | 541.67 Million USD | 2.76% |
| 2023 Q3 | 496.73 Million USD | -8.3% |
| 2023 FY | 2.06 Billion USD | 4.13% |
| 2022 Q3 | 475.51 Million USD | -4.78% |
| 2022 FY | 1.97 Billion USD | 1.06% |
| 2022 Q4 | 493.58 Million USD | 3.8% |
| 2022 Q2 | 499.36 Million USD | -2.33% |
| 2022 Q1 | 511.26 Million USD | -2.37% |
| 2021 Q3 | 493.99 Million USD | 0.89% |
| 2021 Q4 | 523.67 Million USD | 6.01% |
| 2021 Q2 | 489.63 Million USD | 8.41% |
| 2021 Q1 | 451.65 Million USD | 13.69% |
| 2021 FY | 1.95 Billion USD | 42.36% |
| 2020 FY | 1.37 Billion USD | 11.93% |
| 2020 Q4 | 397.27 Million USD | 11.28% |
| 2020 Q2 | 297.32 Million USD | -8.36% |
| 2020 Q1 | 324.43 Million USD | 1.13% |
| 2020 Q3 | 357.01 Million USD | 20.08% |
| 2019 Q2 | 306.79 Million USD | 7.8% |
| 2019 Q1 | 284.61 Million USD | 8.37% |
| 2019 Q3 | 317.19 Million USD | 3.39% |
| 2019 Q4 | 320.8 Million USD | 1.14% |
| 2019 FY | 1.22 Billion USD | 25.28% |
| 2018 Q1 | 229.21 Million USD | 10.04% |
| 2018 FY | 981.3 Million USD | 28.55% |
| 2018 Q2 | 242.89 Million USD | 5.97% |
| 2018 Q3 | 246.57 Million USD | 1.52% |
| 2018 Q4 | 262.62 Million USD | 6.51% |
| 2017 Q1 | 173.95 Million USD | 14.53% |
| 2017 FY | 763.33 Million USD | 34.78% |
| 2017 Q2 | 187.34 Million USD | 7.7% |
| 2017 Q3 | 193.72 Million USD | 3.4% |
| 2017 Q4 | 208.31 Million USD | 7.53% |
| 2016 Q2 | 140.08 Million USD | 10.05% |
| 2016 FY | 566.37 Million USD | 25.45% |
| 2016 Q4 | 151.87 Million USD | 3.23% |
| 2016 Q3 | 147.12 Million USD | 5.03% |
| 2016 Q1 | 127.29 Million USD | 12.18% |
| 2015 Q4 | 113.47 Million USD | -5.07% |
| 2015 FY | 451.47 Million USD | 17.31% |
| 2015 Q1 | 102.16 Million USD | 3.02% |
| 2015 Q2 | 116.3 Million USD | 13.84% |
| 2015 Q3 | 119.53 Million USD | 2.77% |
| 2014 FY | 384.86 Million USD | 14.24% |
| 2014 Q2 | 96.74 Million USD | 1.36% |
| 2014 Q1 | 95.44 Million USD | 14.23% |
| 2014 Q3 | 93.5 Million USD | -3.35% |
| 2014 Q4 | 99.16 Million USD | 6.06% |
| 2013 Q3 | 83.62 Million USD | -2.52% |
| 2013 Q1 | 83.91 Million USD | 8.3% |
| 2013 FY | 336.88 Million USD | 14.51% |
| 2013 Q4 | 83.55 Million USD | -0.09% |
| 2013 Q2 | 85.79 Million USD | 2.24% |
| 2012 Q3 | 71.18 Million USD | -2.21% |
| 2012 Q4 | 77.48 Million USD | 8.85% |
| 2012 Q1 | 72.75 Million USD | 5.26% |
| 2012 FY | 294.2 Million USD | 8.59% |
| 2012 Q2 | 72.78 Million USD | 0.05% |
| 2011 FY | 270.92 Million USD | 32.29% |
| 2011 Q1 | 61.2 Million USD | 7.4% |
| 2011 Q2 | 74.54 Million USD | 21.79% |
| 2011 Q3 | 66.05 Million USD | -11.38% |
| 2011 Q4 | 69.12 Million USD | 4.64% |
| 2010 Q4 | 56.98 Million USD | 7.5% |
| 2010 FY | 204.8 Million USD | -23.06% |
| 2010 Q2 | 41.67 Million USD | -14.97% |
| 2010 Q1 | 49.01 Million USD | -0.3% |
| 2010 Q3 | 53.01 Million USD | 27.2% |
| 2009 Q2 | 51.31 Million USD | 10.33% |
| 2009 FY | 266.18 Million USD | 30.88% |
| 2009 Q3 | 119.19 Million USD | 132.28% |
| 2009 Q4 | 49.16 Million USD | -58.76% |
| 2009 Q1 | 46.51 Million USD | -4.15% |
| 2008 Q4 | 48.52 Million USD | -0.0% |
| 2008 FY | 203.38 Million USD | 15.92% |
| 2008 Q3 | 48.52 Million USD | -13.01% |
| 2008 Q2 | 55.78 Million USD | 10.38% |
| 2008 Q1 | 50.54 Million USD | 4.47% |
| 2007 Q1 | 39.23 Million USD | -30.02% |
| 2007 Q2 | 42.9 Million USD | 9.37% |
| 2007 Q3 | 44.92 Million USD | 4.7% |
| 2007 FY | 175.44 Million USD | -2.05% |
| 2007 Q4 | 48.37 Million USD | 7.69% |
| 2006 Q4 | 56.06 Million USD | 29.74% |
| 2006 FY | 179.11 Million USD | 27.13% |
| 2006 Q3 | 43.21 Million USD | 7.97% |
| 2006 Q1 | 39.82 Million USD | 17.86% |
| 2006 Q2 | 40.02 Million USD | 0.49% |
| 2005 FY | 140.89 Million USD | 33.5% |
| 2005 Q1 | 33.54 Million USD | 19.65% |
| 2005 Q2 | 36.12 Million USD | 7.69% |
| 2005 Q4 | 33.79 Million USD | -9.72% |
| 2005 Q3 | 37.43 Million USD | 3.61% |
| 2004 FY | 105.53 Million USD | 15.85% |
| 2004 Q1 | 24.89 Million USD | 7.74% |
| 2004 Q2 | 25.61 Million USD | 2.88% |
| 2004 Q3 | 26.99 Million USD | 5.39% |
| 2004 Q4 | 28.03 Million USD | 3.87% |
| 2003 FY | 91.09 Million USD | -6.7% |
| 2003 Q2 | 24.14 Million USD | 12.24% |
| 2003 Q4 | 23.1 Million USD | 3.43% |
| 2003 Q1 | 21.5 Million USD | -13.13% |
| 2003 Q3 | 22.34 Million USD | -7.46% |
| 2002 Q1 | 23.43 Million USD | 2.14% |
| 2002 FY | 97.64 Million USD | -0.77% |
| 2002 Q4 | 24.76 Million USD | 1.83% |
| 2002 Q3 | 24.31 Million USD | -2.87% |
| 2002 Q2 | 25.03 Million USD | 6.82% |
| 2001 Q2 | 23.22 Million USD | -15.75% |
| 2001 Q1 | 27.56 Million USD | 0.0% |
| 2001 FY | 98.39 Million USD | 45.55% |
| 2001 Q4 | 22.94 Million USD | -7.0% |
| 2001 Q3 | 24.67 Million USD | 6.26% |
| 2000 FY | 67.6 Million USD | 405.95% |
| 2000 Q1 | 6.65 Million USD | 0.0% |
| 1999 FY | 13.36 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -18403.43% |
| Cerus Corporation | 143.15 Million USD | -1350.753% |
| OrthoPediatrics Corp. | 137.01 Million USD | -1415.72% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -18180.517% |
| Talis Biomedical Corporation | 67.18 Million USD | -2991.157% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -8225.283% |
| Inogen, Inc. | 236.08 Million USD | -779.694% |
| Spectral AI, Inc. | 20.86 Million USD | -9854.108% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -3608.815% |
| CVRx, Inc. | 76.14 Million USD | -2627.568% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -58766.989% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -16529.234% |
| Orthofix Medical Inc. | 667.42 Million USD | -211.169% |
| Venus Concept Inc. | 80.47 Million USD | -2480.676% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -3570.729% |
| Bioventus Inc. | 409.91 Million USD | -406.644% |
| BrainsWay Ltd. | 28.01 Million USD | -7312.467% |
| Envoy Medical, Inc. | 17.89 Million USD | -11503.671% |
| electroCore, Inc. | 32.03 Million USD | -6383.797% |
| IceCure Medical Ltd | 16.87 Million USD | -12206.382% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -4794.478% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -11678.039% |
| MaxCyte, Inc. | 84.84 Million USD | -2347.787% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -16632.71% |
| Nexalin Technology, Inc. | 5.78 Million USD | -35822.801% |
| PAVmed Inc | 64.82 Million USD | -3103.642% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -3965.987% |
| RxSight, Inc. | 103.85 Million USD | -1899.831% |
| Sight Sciences, Inc. | 126.44 Million USD | -1542.421% |
| SI-BONE, Inc. | 156.35 Million USD | -1228.309% |
| TELA Bio, Inc. | 84.18 Million USD | -2366.919% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -2864.521% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -921.23% |
| LivaNova PLC | 843.54 Million USD | -146.201% |
| 908 Devices Inc. | 68.08 Million USD | -2950.566% |
| Alphatec Holdings, Inc. | 483.59 Million USD | -329.453% |
| Nemaura Medical Inc. | 7.13 Million USD | -28992.062% |
| NeuroPace, Inc. | 75.29 Million USD | -2658.214% |
| LENSAR, Inc. | 33.33 Million USD | -6129.977% |
| Apyx Medical Corporation | 51.01 Million USD | -3970.769% |
| Cutera, Inc. | 197.72 Million USD | -950.366% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -8280.715% |
| BioSig Technologies, Inc. | 28.53 Million USD | -7179.443% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -984.646% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -5659.359% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | -148.308% |
| Axonics, Inc. | 270.2 Million USD | -668.619% |
| Outset Medical, Inc. | 198.77 Million USD | -944.838% |
| IRIDEX Corporation | 31.81 Million USD | -6428.022% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -1052.39% |
| IRadimed Corporation | 30.12 Million USD | -6794.526% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -24241.596% |
| INVO Bioscience, Inc. | 7.85 Million USD | -26345.276% |
| Telesis Bio, Inc. | 63.48 Million USD | -3171.157% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -2009.458% |
| Varex Imaging Corporation | 224.8 Million USD | -823.855% |
| Quipt Home Medical Corp. | 148.66 Million USD | -1296.964% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -17615.815% |
| Pulmonx Corporation | 112.68 Million USD | -1743.003% |
| Dynatronics Corporation | 9.9 Million USD | -20861.037% |
| Modular Medical, Inc. | 17.52 Million USD | -11747.938% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -10187.933% |
| Semler Scientific, Inc. | 38.94 Million USD | -5232.85% |
| InMode Ltd. | 215.68 Million USD | -862.92% |
| Bruker Corporation | 1.07 Billion USD | -92.942% |
| Cytosorbents Corporation | 48.33 Million USD | -4196.567% |
| DexCom, Inc. | 1.69 Billion USD | -22.802% |
| Viveve Medical, Inc. | 22.17 Million USD | -9266.459% |
| ZimVie Inc. | 275.12 Million USD | -654.863% |
| Movano Inc. | 29.69 Million USD | -6895.032% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -1412.938% |
| Nexalin Technology, Inc. | 5.78 Million USD | -35822.801% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -58766.989% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | -245.608% |
| Profound Medical Corp. | 33.6 Million USD | -6080.448% |
| Insulet Corporation | 939.9 Million USD | -120.962% |
| enVVeno Medical Corporation | 25.23 Million USD | -8128.96% |
| Surmodics, Inc. | 98.69 Million USD | -2004.243% |
| iCAD, Inc. | 22.22 Million USD | -9244.544% |
| Nuwellis, Inc. | 22.61 Million USD | -9084.208% |
| Biotricity, Inc. | 17.18 Million USD | -11985.42% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -365.772% |
| Aethlon Medical, Inc. | 12.27 Million USD | -16815.684% |
| InspireMD, Inc. | 22.95 Million USD | -8949.346% |
| PAVmed Inc. | 64.82 Million USD | -3103.642% |
| BIOLASE, Inc. | 34.66 Million USD | -5891.821% |
| Beyond Air, Inc. | 61.7 Million USD | -3266.005% |
| FONAR Corporation | 28.6 Million USD | -7160.438% |
| AxoGen, Inc. | 149.33 Million USD | -1290.706% |
| Vivani Medical, Inc. | 26.96 Million USD | -7601.928% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -1072.738% |
| Inari Medical, Inc. | 448.59 Million USD | -362.961% |
| UFP Technologies, Inc. | 58.08 Million USD | -3475.247% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -42046.794% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -32770.054% |
| Tenon Medical, Inc. | 16.96 Million USD | -12139.657% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -27991.776% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -4609.05% |
| AdaptHealth Corp. | 1.07 Billion USD | -92.662% |
| Sintx Technologies, Inc. | 15.2 Million USD | -13562.424% |
| NanoVibronix, Inc. | 4.97 Million USD | -41662.015% |
| Quanterix Corporation | 118.1 Million USD | -1658.531% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -17615.815% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -14280.453% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -428.904% |
| TransMedics Group, Inc. | 182.82 Million USD | -1035.994% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -7300.053% |
| NeuroMetrix, Inc. | 11.09 Million USD | -18611.932% |
| Hyperfine, Inc. | 52.87 Million USD | -3828.024% |
| Establishment Labs Holdings Inc. | 172 Million USD | -1107.435% |
| Biomerica, Inc. | 6.97 Million USD | -29662.468% |
| Bone Biologics Corporation | 9.42 Million USD | -21927.559% |
| AVITA Medical, Inc. | 80.77 Million USD | -2470.989% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -20041.417% |
| Silk Road Medical, Inc | 186.35 Million USD | -1014.434% |